This week, Tandem Diabetes Care (Nasdaq:TNDM) announced a major milestone for its Mobi miniature durable insulin pump system. San Diego-based Tandem revealed that it received FDA approval for the Android version of its Mobi mobile app. Clearance brings Mobi — which the company describes as the world’s smallest, durable automated insulin delivery system — to […]
Tandem Diabetes Care
Tandem wins FDA nod to pair Mobi pump with Android smartphones
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received FDA approval for the Android version of its Mobi mobile app. Clearance brings Mobi — which the company describes as the world’s smallest, durable automated insulin delivery system — to more users. The pump, which pairs with Tandem’s Control-IQ+ algorithm, previously worked with iOS software. Tandem’s […]
Tandem stock rises after hours on Q3 beats, record sales
Tandem Diabetes Care (Nasdaq:TNDM) shares got a boost after hours today on third-quarter results that came in ahead of the consensus forecast. Shares of TNDM rose nearly 20% to $15.89 apiece in post-market trading today. The San Diego-based automated insulin delivery technology developer reported losses of $21.2 million. That equals 31¢ per share on sales […]
Tandem achieves cybersecurity certification milestone
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it achieved ISO/IEC 27001:2022 Certification from Insight Assurance. San Diego-based Tandem said the certification affirms its commitment to cybersecurity, data protection and operational integrity. As it looks to expand internationally, it says the certification strengthens its position in regulated markets. It also simplifies compliance for partners and healthcare […]
Tandem launches t:slim X2 pump with Abbott FreeStyle Libre 3 Plus
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it launched its t:slim X2 insulin pump with the Abbott (NYSE:ABT) FreeStyle Libre 3 Plus CGM. The new pairing combines Tandem’s flagship automated insulin delivery system with Control-IQ+ technology with Abbott’s latest continuous glucose monitor (CGM) sensor in the U.S. Tandem teased the launch on social media earlier […]
Tandem says Abbott FreeStyle Libre 3 integration is ‘coming soon’
On social media, Tandem Diabetes Care (Nasdaq:TNDM) said the launch of a new integration for its insulin pump system is near. “It’s almost here! The t:slim X2 insulin pump integration with the FreeStyle Libre 3 Plus sensor, the world’s smallest continuous glucose monitor, is coming soon,” Tandem wrote on LinkedIn. Tandem announced that it was […]
Tandem t:slim X2 pump cleared for use with Lilly’s Lyumjev ultra-rapid insulin
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received approval to deliver Lyumjev ultra-rapid acting insulin with its t:slim X2 pump. Eli Lilly offers the Lyumjev (insulin lispro-aabc injection) ultra-rapid acting insulin. Tandem can now provide its t:slim X2 pump with Control-IQ+ automated insulin delivery technology with the insulin in the U.S. This latest clearance […]
Tandem reports positive outcomes for automated insulin delivery in type 2 regardless of C-peptide levels
Tandem Diabetes Care (Nasdaq:TNDM) today announced study findings highlighting the benefits of its automated insulin delivery system. Findings from the “Adults with Type 2 Diabetes Benefit from Automated Insulin Delivery Irrespective of C-peptide Level” study were published in the American Diabetes Association’s Diabetes Care. The study, a sub-analysis from the 2IQP trial, found that Control-IQ+ automated […]
Tandem wins nod in Canada for smartphone app to control t:slim X2 automated insulin pump
Tandem Diabetes Care (Nasdaq:TNDM) announced today that Health Canada authorized its t:slim mobile application for Android and iPhone users. Authorization allows users of the t:slim X2 automated insulin delivery system to deliver a bolus from their compatible smartphone. They can also wirelessly upload pump data to the cloud-based Tandem Source platform. Tandem — one of the largest […]
Tandem picks up FDA clearance for 7-day infusion set
The FDA’s 510(k) database indicates that Tandem Diabetes Care (Nasdaq:TNDM) recently received clearance for an extended-wear infusion set. Tandem’s Capillary Biomedical (CapBio) subsidiary develops the SteadiSet Infusion Set. The wearable infusion set delivers insulin from an insulin pump to the body. Tandem — one of the largest diabetes tech companies in the world — develops the t:slim X2 and […]
